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An investigation of the antigenic mimicry between murine macro­
phages and 1ipopolysaccharide (LPS) from Escherichia coli 0113
Director: Dr, Jon A. Kudbach
Mice treated with toxins for macrophages such as carregeenan 
and Min-U-Sil., are primed immunologically for a pseudosecondary 
antibody response, which can be triggered by 1ipopolysaccharide 
(LPS) from Escherichia coli (E. coli 0113) given 21 days later. 
Since the priming for a pseudosecondary antibody response was 
coincidental with macrophage (or more specifically, lysosomal) 
damage, it was hypothesized that antigenic similarities existed 
between LPS from E, coli 0113 and the lysosomal contents. To 
test this, murine macrophages, disrupted by repeated freeze-thaw 
cycles, were used to prime homologous mice, which were then 
challenged 21 days later with a single dose of LPS from E. coli 0113. These mice gave a titer that was comparable in magnitude 
to the titer of a true secondary antibody response of mice that 
received two doses of LPS. In a radioimmunoassay, extracts of 
macrophages inhibited the binding of LPS from E, coli 0113 to its specific antibody. Furthermore, an immunochemical cross­
reaction was demonstrated between products from macrophages and 
LPS from E. coli 0113, by use of a radioactive binding assay. 
Proteinase I is a lysosomal product from Dictyostelium discoideum 
It contains N-acetylglucosamine-1-phosphate residues, which are 
thought to share structural similarities with the oligossacharide 
portions of the LPS molecule. An immunochemical cross-reactivity 
was demonstrated between the two systems. Immunochemical/immuno­
logical relationships were found to occur between the products 
from the macrophage (or lysosome), LPS from £. coli 0113, and 
lysosomal proteinase I. These data suggested that the pseudo­
secondary antibody response, generated by priming mice with 
products from macrophage followed by challenge with LPS, was due 
to the antigenic mimicry between determinants on LPS from E. coli 
0113 and the same, or closely related determinant(s) in the 
macrophage (or more specifically, lysosomal products).
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INTRODUCTION
When an animal initially is presented with an antigen, 
the animal responds by producing antibodies against that 
particular antigen. The antibodies are first detectable 
after 1 to 3 0 days of antigen presentation. The lag varies 
with dose, route of injection, nature of the antigen (soluble 
or particulate), and the type of adjuvant used (24).
Normally, the antibodies appear in the serum after a few 
days, increase until about the second week and then decline 
slowly over a period of weeks or months (92). If the animal 
is challenged with the same or a structurally related 
antigen a few days after the first appearance of the antigen, 
there is a shortened lag period, an increase in the rate of 
synthesis, and an increase in the quantity of antibodies 
produced by the animal within 2 to 3 days of the challenge. 
The first antibody response is called a primary response, 
which is characterized by the synthesis of antibodies of the 
IgM (19S) isotype and little or no IgG (7S) antibodies (92). 
The secondary antibody response usually is characterized by 
a large increase in antibodies of the IgG isotype, but not 
in IgM antibodies- If the antibody is still present in the 
serum when the challenge antigen is given, the antibody 
declines or disappears at once (negative phase) because of
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its immediate reaction with the antigen, to form complexes 
(immune clearance) (9 2). Shortly thereafter, the titer of 
the antibody rises sharply, then drops sharply after a few 
days, and gradually declines over a peiod of weeks or months 
Another type of secondary antibody response is 
observed when cross-reacting antigens are administered, 
sequentially, to an animal. An animal challenged with a 
molecule closely related to the molecule used for priming 
(1st exposure to the molecule), responds by producing anti­
bodies comparable in magnitude to the response obtained by 
using two doses of the same molecule. This phenomenon is 
in line with the concept of "original antigenic sin" (26). 
This concept of "original antigenic sin" deals with the 
affinity of antibodies to an antigen, and the memory cells, 
which are stimulated by the antigen. If an animal was 
immunized with, for example, DNP-bovine gamma globulin and 
challenged days later with TNP-bovine gamma globulin, the 
antibodies generated will have a higher affinity for DNP, 
even though TNP was used for the challenge. When the animal 
was first immunized with DNP-BCG, a large number of memory 
cells specific for the DNP were generated. So when 
challenged with the TNP-BCG, most of the DNP memory cells 
and a few TNP memory cells were activated. Since the result 
would be many more anti-DNP molecules, most of the antibody 
would have this affinity. So the concept is that a popula­
tion of memory cells will be formed because of a primary
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exposure to a given antigen; the memory cells will become 
activated by any antigen they recognize, but will produce 
antibody that has the greatest affinity to the first priming 
antigen (26,27).
Becker and Rudbach (9,10), demonstrated that macrophage 
toxins induced an unusual antibody response to LPS from 
Escherichia coli 0113 in mice, which they termed a "pseudo­
secondary response". They showed that mice treated with 
toxins for macrophages, such as carrageenan and micro­
particulate crystalline silica, generated a secondary-like 
antibody response to LPS when the treated animals were 
challenged with a single dose of LPS from E. coli 0113 
strain, 21 days after toxin treatment (73). Since an animal 
could only respond in a secondary fashion if there were 
cross-stimulation between the priming antigen and the 
challenge antigen, the question then was, how did these 
toxins affect the macrophage, and what product(s) were 
responsible for priming for the secondary anti-LPS response?
Theories have been postulated for the mechanism by 
which carrageenan and crystalline silica damage macrophages 
(1,6,7,50,70,71,83). One of the mechanisms of the action 
of carrageenan is the destabilization of the lysosomes. 
Carrageenan belongs to a class of polysaccharides known 
as gel-forming polysaccharides (6,70), having both a second­
ary and a tertiary structure. Because of its unique struc­
ture this (carrageenan) high molecular weight sulfated poly-
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galactose is resistant to rapid digestion by lysosomal 
glycosidases (21). When carrageenan is taken up by phago­
cytosis, it is transported to the secondary lysosomes. 
However, much of the carrageenan is not digested down to the 
level where it is freely diffusible. This results in 
lysosomal swelling and leads to the rupture of the lysosomal 
membrane with consequent release of carrageenan and lyso­
somal hydrolases (70). It is believed that the products 
released from the macrophage, rather than carrageenan itself, 
were responsible for priming for a secondary anti-LPS 
response (73)- The end result of the mechanism of action of 
microparticulate crystalline silica (Min-U-Sil) on the 
macrophage is similar to that of carrageenan. One of the 
mechanisms of action of silica is that the silica particles 
react relatively rapidly with the membranes surrounding 
the secondary lysosomes after phagocytosis of the particles. 
This results in the release of undegraded particles and 
hydrolases. It is suggested that hydrogen bonding of 
silicic acid with lipid and protein constituents of the 
membrane accounts for the induced permeability (1).
The concept that a pseudo-secondary antibody response 
to LPS appears to be dependent on the presence of products 
released from the macrophage originated from the recent 
investigation of Remington (73). Remington's investigation 
involved the use of stabilized thorium dioxide (Thorotrast), 
a compound that blocks the reticuloendothelial system of
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mice, but does not cause macrophage destabilization. The 
data generated from these investigations showed that the 
pseudosecondary antibody response could not be generated 
when mice treated with Thorotrast were challenged with a 
single dose of LPS from E. coli 0113, 21 days later. This 
investigation, by Remington, confirmed the fact that only 
those macrophage toxins that produced lysosomal destabiliza­
tion and subsequent cytotoxicity could prime mice for a 
pseudosecondary antibody response. Critical to the inter­
pretation of this observation, was the finding that the 
functional state of the reticuloendothelial system was 
normal at the time of the generation of the pseudosecondary 
antibody response. The macrophages of mice treated with CAR 
or silica were depleted as a result of the action of these 
toxins only for a few days after treatment (1,70). The 
normal or enhanced phagocytic activity which was observed, 
was due to a new population of macrophages. In addition to 
this. Remington's work also showed that the kinetic require­
ments for the generation of pseudosecondary antibody response 
was the same as that of a true secondary antibody response. 
The pseudosecondary antibody response, required at least a 
10-day interval between the administration of the macrophage 
toxin and the challenge with LPS, just like the true second­
ary antibody response. These data showed that the difference 
between the pseudosecondary antibody response and the true 
secondary response was at the level of priming. The factors
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released from macrophages apparently were sufficient to 
substitute for the LPS molecule at the priming stage. Con­
sequently, when the mice were challenged with LPS 21 days 
later, the previously sensitized memory cells (B-lympho­
cytes) generated a pseudosecondary antibody response. The 
priming could not have been as a result of the macrophage 
toxins themselves, although carrageenan and LPS 0113 do 
share some structural similarities (55,62); because, as the 
above data indicated, silica which bears no structural 
similarity to LPS 0113 also generated the pseudosecondary 
antibody response. Based on the above findings, it was 
hypothesized that materials released from the damaged macro­
phage, as a result of the action of the carrageenan or Min- 
U-Sil, specifically primed the mice to give the observed 
pseudosecondary antibody response, when these animals were 
challenged with a single dose of LPS from E. coli 0113, 21 
days later (73).
Macrophages are involved in the initiation and regula­
tion of both the humoral and cellular aspects of the immune 
response (83). One of the broad areas in which macrophages 
have been actively involved in immunity is in the secretion 
of a variety of biologically active substances. These sub­
stances include C components, products active in the 
inflammatory process and in non-specific regulation of T and 
B lymphocyte functions, and also a variety of acid hydrolases 
The events leading to the production of these substances in
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some cases start with the uptake, catabolism, and presenta­
tion of the antigen to T cells and B cells. Macrophages 
remove antigens from the extracellular fluids by the process 
of phagocytosis. During this process, the macrophage 
appears to retain only a small fraction of the antigen taken 
up, while the greater bulk of the antigen is degraded. This 
is called "antigen processing". The undegraded molecules of 
antigen are immunologically active and can persist in the 
tissues for prolonged periods of time (62). The processed 
antigen, which is now potentially immunogenic, is presented 
to the responding antigen-specific T and/or B lymphocytes, 
the later of which provide for the production of antibodies.
Antigen presentation by macrophages, serves important 
immunoregulatory functions. The antigen may be presented 
in a way, such that one side of the balance between antibody 
production and cell mediated immune response may be favored 
over the other (16). In addition, the way that the antigen 
is presented determines the extent or magnitude of the anti­
body response, since the balance between the stimulation of 
the T lymphocyte subsets is important in the regulation of 
the immune response.
Bacterial 1ipopolysaccharide (LPS) is a complex 
molecule. In its native form it consists of three regions, 
covalently bonded together. These regions are called Lipid 
A, a core polysaccharide moiety, and 0-specific antigenic 
polysaccharide side chain (28,59). The O-specific side
8
portion, besides functioning as the site that determines 
the antigenic specificity of the organism, also functions 
as a receptor for bacteriophages (79). The core poly­
saccharide region is relatively similar within certain 
classes of bacteria. Its major function is for maintenance 
of the integrity of the outer membrane besides functioning 
as a chemical bridge between the hydrophobic Lipid A and the 
hydrophilic 0-antigenic determinant. Marsh, et a l ., (79)
have shown that in rough mutants, which lack most of the 
core polysaccharide region, there is an increase in perme­
ability to hydrophobic compounds (2,45,85). The same 
phenomenon was also reported when LPS was partially released 
from the membrane on treatment with EDTA (48). Studies with 
different genera of gram negative bacteria showed that two 
substances were common to the core polysaccharide region 
of the LPS molecule. These substances were, 1-glycero-D- 
manno-heptose (heptose) and 2-keto-3-deoxyoctonate (KDO)
(6 7). The heptose portion served as an attachment site for 
other carbohydrate molecules. The KDO portion on the other 
hand served as a link between the Lipid A moiety and the 
core polysaccharide region by means of glycosidic bonds 
(53,67). The KDO portion of the core polysaccharide region 
is found in most gram negative bacteria. The only mutants 
that lack the genes for the synthesis of KDO region are the 
temperature sensitive types (46,77,78).
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Physically, the Lipid A portion of LPS molecules is 
water insoluble, but soluble in methanol and chloroform 
(93,94). Chemically, it is made up of 1) a carbohydrate 
backbone of glucosamine molecules which are linked by 
glycosidic and phosphodiester bonds, and 2) various long 
chain fatty acids esterified to the hydroxyl residues of 
the glucosamine backbone (54).
The Lipid A portion of LPS has been shown to be 
responsible for much of the biological activities of the 
LPS (5,18,43,69), although the mechanism of action is not 
fully understood. It was postulated that Lipid A was 
responsible for the mitogenic and polyclonal activation of 
B cells, in addition to the adjuvant effect (5,18,30,41,56, 
62,63,69). However, there is also an increasing body of 
evidence to show that other parts of LPS, such as the core 
polysaccharide region, can also induce immune suppression 
(35)- The Lipid A portion of LPS activates antibody forming 
cell precursors (AFCP), to produce specific antibodies to 
T-dependent antigens (88). Some investigators (15,19) have 
postulated that LPS acts directly on B cells, as a second 
signal in the framework of a two signal model of immunity 
(14,20). The first signal involves the antigenic signal 
which is the specific binding of immunodeterminant groups 
to immunoglobulin-like receptors on the surface of a B cell. 
The second signal is the non-specific signal that resides 
inherently in the Lipid A portion of the LPS molecule (5,18,
10
44,9 0). However, others maintain that the mitogenic 
activity of LPS alone is required for triggering AFCP (23). 
The triggering events for these B cells involve an initial 
recognition of the Lipid A region of LPS. Consequently, 
this initial interaction results in a pertubational event, 
that leads to a transfer of informational signals to the 
appropriate cells (61). Some of the postulated mechanisms 
of this triggering involve the insertion of LPS into the 
phospholipid layer with the subsequent destabilization of 
the Lipid A (LPS) receptors either by direct translocation 
or by endocytosis/pinocytosis.
LPS also mediates modulations of both the efferent and 
afferent limbs of the immune response (62). LPS has been 
used as a stimulant in several studies using peritoneal 
exudate cells (macrophage) to provide for a generalized 
increase in most enzymes (31). The proposition that lyso­
somes may be the target for the effects of endotoxin (LPS) 
is supported by the observation that lysosomes from endo­
toxin-treated mice were more fragile than those isolated 
from untreated mice (12). LPS has a suppressive effect on 
the reticuloendothelial system (RES) and several investiga­
tions support the concept of LPS toxicity to macrophages 
(11,49,77). This mechanism of action could be compared to 
the action of carrageenan and Min-U-Sil on macrophages.
Quan et a l ., (71) have reported a synergistic effect between
carrageenan and LPS, although the reason for this is not
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clear. Analogous results have also been reported by Becker 
and Rudbach (9), confirming the potentiation of endotoxicity 
to carrageenan. Several workers (17,38) have reported a 
depression of the antibody response to thymus-independent 
antigens when the RES activity was depressed by carrageenan. 
It was speculated that this depression of the antibody 
response might have been caused by an immunosuppressive 
factor released by damaged macrophages (71). These data 
indicated that the antibody response to the thymus-independ­
ent antigen studied was macrophage dependent. In contrast 
to the above finding of depressed antibody response, when 
the RES was damaged by carrageenan, other workers (38) have 
reported a normal antibody response to thymus-independent 
antigens after treatment with carrageenan. In some cases, 
an increase in the antibody response was noted (38); this 
confirmed the data which indicated that the antibody response 
was macrophage-independent. Obviously, the interpretation 
of these reports is still unclear.
Primarily, through the study of a heptose-less mutant 
of E. coli K-12, various investigators have elucidated part 
of the complex core and Lipid A structure of LPS molecule 
(77,78,79). These studies showed that LPS consists of two 
types of phosphorylated D-glucosamine disaccharide units, 
designated as LPS-1 and LPS-2. The two species are basically 
the same except that LPS-2 has a pyrophosphate group at the 
glycosyl position instead of the phosphomonoester group in
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LPS-1. The phosphomonoester groups of LPS-1 are at the 4- 
hydroxyl group but a pyrophosphate group is attached to the 
anomeric carbon. These data show that part of the oligo­
saccharide portion of the LPS has structural similarities 
to a terminal sugar N-acetyl glucosamine-1-phosphate (GlcN 
Ac-l-P) found in some glycoproteins (3 2).
Most of the lysosomal hydrolases of animals are glyco­
proteins. Glycoproteins are widely distributed in nature 
and belong to a class of conjugated proteins which contain 
carbohydrate groups attached covalently to the polypeptide 
chains. There is a growing body of evidence to suggest 
that cell-surface glycoproteins are involved in a number of 
physiologically important functions, such as cell-cell inter­
actions, adhesion of cells to substrates, migration of cells 
to particular organs, etc. (36,37).
Gustafson, et al., have isolated in a purified form, 
a lysosomal proteinase called proteinase 1 from the cellular 
slime mold, Dictyostelium discoideum. The proteinase I is 
an endopeptidase, the subunits of which were shown to be 
tightly associated or covalently bonded with phosphoryl 
moieties (33). Subsequent analysis showed that all of the 
phosphate associated with the proteinase I, was in form of 
a sugar-phosphate identified as the alpha-anomer of N-acetyl- 
glucosamine-l-phosphate (3 2).
The lysosome of Dictyostelium discoideum contains 
several glycosidases, most of which are thought to share a
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common antigenic determinant(s) (72). A recent study by 
Gustafson, et al., (34) indicated an immunological relation­
ship between one of such glycosidases, (B-N-acetylgucos- 
aminidase) and proteinase I. The study proposed that the 
phosphoryl moieties might be the common antigenic determi­
nant in the two enzymes. The occurence of glycosyl- 
phosphoryl moieties, as the immunodominant groups in many 
organisms that have oligosaccharide cell walls, have been 
documented (40).
STATEMENT OF THESIS AND APPROACH TO THE PROBLEM
It was shown that mice treated with toxins for macro­
phages, like carrageenan and Min-U-Sil, generated a pseudo­
secondary antibody response after challenge with a single 
dose of LPS from E. coli 0113, 21 days later (73). Since 
the previous work had demonstrated that priming for a pseudo- 
secondary antibody response was coincidental with macrophage 
(or more specifically, lysosomal) damage, the purpose of 
the present study was to investigate immunological/immuno­
chemical relationships between LPS, macrophages (or lyso- 
somes), and lysosomal products.
The study of these relationships was approached as 
follows ;
1. Macrophages from the peritoneal cavity of mice were 
isolated and fractionated. Also tritosomes were prepared 
from mouse livers.
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2. Attempts were made to prime mice for pseudosecondary 
antibody responses to LPS with the crude lysates, the 
lysosomal fractions and the supernatant fluid fractions of 
the cells.
3. C3H/HeJ mice which are non-responders to LPS were used 
with the above macrophage fractions to investigate the 
genetic requirements of the pseudosecondary antibody response.
4. Several radioimmunoassays were developed and were used 
to investigate immunological cross-reactions between LPS, 
macrophage (lysosomal) extracts, the lysosomal proteinase
I from the cellular slime mold, and their respective antigens, 
with each other.
5. Finally, an attempt was made to establish more precisely 
the nature of the cross-reacting component in the LPS, 
through the use of SDS-polyacrilamide gel electrophoresis.
This technique included the use of "Western blot" to conju­
gate covalently, the proteins (from the proteinase I after 
electrophoresis) to a diazobenzyloxy-methyl paper. The 
exposed proteins were stained with the homologous antisera 
and LPS.
The results of the above study showed that there was 
a distinct determinant(s) in the macrophage lysate that 
cross-reacted with the LPS molecule. Furthermore, the study 
showed that this determinant(s) in the LPS, cross-reacted 
immunochemically with the proteinase I from the cellular 
slime mold.
II. MATERIALS AND METHOD
Animals. (i). RML mice. Both sexes of the N.NIH Swiss-
Webster mice derived from the Rocky Mountain Laboratories 
(RML), Hamilton, Montana, were used for most of the experi­
ments. This strain of mice have retained nearly the same 
genetic variation found in natural murine populations (74). 
The mice were fed the regular lab chows and water a^ libitum 
The age of the mice was between 4-8 weeks.
(ii). C3H/HeJ mice. The experiments were performed on 6-8 
week old male C3H/HeJ mice purchased from Jackson Labora­
tories (Bar Harbor, Michigan). They were fed standard lab 
chow and water a^ libitum.
Macrophage Toxins : (i) . Carrageenan. Calcium carrageenan
in the form of Sea Kem-9 was purchased from Marine Colloids 
(Springfield, New Jersey). Before injection, the dry 
carrageenan was weighed out and suspended in warm (37°C) 
phosphate buffered Saline (PBS) (0.15M NaCl, 0.0033M PO^; 
pH 7.2). Each injection was by the intraperitoneal route-
(ii). Microparticulate crystalline silica (Min-U-Sil). 
Silica particles (Min-U-Sil, Whittaker, Clark and Daniels, 
Inc., New York, NY), which has an average size of less that 
5ym, were further fractionated according to the method
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described by Becker and Rudbach (8,10). Briefly, 50 g of 
silica were suspended in 500 ml of distilled, deionized 
water, and subjected to ultrasonic vibrations (Branson, 
Danbury, Connecticut) at room temperature for 3 0 sec. The 
suspension was diluted with an equal volume (500 ml) of 
distilled deionized water in a 1 & graduated cylinder. This 
was allowed to settle at room temperature for 24 hr. Frac­
tion III (MUS), corresponding to the 500-700 ml portion from 
the top of the cylinder, was removed and washed two times 
with distilled, deionized water. It was dried in a warm 
(60°C) oven for 48 hr. Before injection, the dry MUS was 
weighed and resuspended to the desired concentration (2 mg/ 
ml) in sterile PBS.
Lipopolysaccharide. (i). LPS from E. coli 0113. The lipo-
polysaccharide (LPS) from E. coli 0113 (Braude strain) 
supplied by Rudbach, was prepared from a phenol-water extract 
by the method described by Rudbach, et al., (81). The dried 
preparation was dissolved in PBS in a 2 mg/ml stock solution. 
This was stored in small vials at -20®C. Appropriate dilu­
tions of the stock solution were made immediately before use.
(ii) . LPS from E. coli K235. The 1ipopolysaccharide (LPS) 
from E. coli K23 5 supplied by Rudbach, was prepared by the 
method described by MeIntire, et al., (57). The dried 
preparation was dissolved in PBS at a stock concentration of 
2 mg/ml. This was stored in small vials at -20®C. Appro-
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priate dilutions of the stock were made just before use.
Native protoplasmic polysaccharide (NPP). The native proto­
plasmic polysaccharide, supplied by Rudbach, was prepared 
by the method described by Anacker, et al., (3,60). The 
dried preparation was dissolved in PBS at a stock concentra­
tion of 2 mg/ml. This was stored in small vials at -20®C. 
Appropriate dilutions of the stock were made just before 
use. NPP is antigenically similar to purified LPS from 
E. coli 0113, but lacks lipid A (3,4,60).
Macrophage Extracts. Peritoneal exudate cells (PEC) were 
stimulated in mice by the i.p. injection of 2 ml of 3% 
thioglycolate broth (Difco Laboratories, Detroit, Michigan) 
or injection of 1 ml of 10% protease peptone broth #3 (Difco 
Laboratories, Detroit, Michigan). After 3 d, the mice were 
killed by rapid cervical dislocation and the PEC harvested 
as described by Stuart, et al., (86). Briefly, the abdominal 
cavity was wetted with alcohol and the skin from the abdomi­
nal wall removed, thus exposing the skin. Then, 3 ml of 
sterile double strength Eagles Minimal Essential Medium 
(EMEM) (Grand Island Biological Company, Grand Island, NY) 
was injected into the peritoneal cavity. The fluid was 
circulated by prodding (massaging) the abdominal area. After 
about 3 min, the peritoneal fluid was aspirated and placed 
into a chilled (4°C) siliconized (Sili-Clad, Clay Adams, 
Parsippany, NJ.) tube. The cells were centrifuged at 1,000
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X g for 10 min at 4®C, and then washed twice in PBS.
Fractionation of the harvested macrophage. The fractiona­
tion procedure was the method described by Werb et al., (9 5) . 
The washed PEC were counted in a hemocytome ter and adjusted
pto a concentration of 3.5 x 10 cells/ml with PBS. This was 
suspended in 40 ml of 0.25 M sucrose in 2 mM Ethylenediamine 
Tetraacetic acid (EDTA) (Fisher Scientific Co., Fairlawn,NJ.) 
The cells were homogenized in a mechanically driven Teflon 
pestle (National Appliance Company, Portland, OR.). Approx­
imately 10-20 strokes were sufficient for complete homogeni­
zation. The homogenate was diluted 2:1 with cold 8.5% 
sucrose. This was centrifuged at 1,000 x g for 12 min at 
4°C. The milky supernatant part (soluble fraction) was re­
centrifuged at 12,000 X g for 10 min at 4°C. The pellet was 
suspended in 50 mM tricine buffer, pH 8.0, and this consti-^ 
tuted the 12,000 x g lysosomal and mitochondrial fraction.
The supernatant fluid fraction contained the soluble hydrol­
ases, microsomes, and other soluble proteins.
Macrophage Lysate. (i). Total macrophage lysate. The
total macrophage lysate was prepared by 6 cycles of freeze- 
thawing (at -60°C) of the washed cells.
Preparation of liver tritosomes from mice. The method used 
was that described by Leighton, et al., (47) with certain 
modifications (89). Mice were injected i.p. with an aqueous 
solution (26% w/v) of Triton WR-133 9 (TYLOXAPOL) (Sigma
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Chemical Co., St. Louis, MO.) in a dose of 85 mg/100 g body 
weight. The mice were fasted overnight, on the second day 
after injection. On the third day, the mice were killed by 
rapid cervical dislocation and the livers were removed and 
weighed. The livers were homogenized in a mechanically 
driven Teflon pestle in 0.25 M sucrose containing 1 mM EDTA. 
Approximately 10-20 strokes were sufficient for complete 
homogenization. The homogenate was centrifuged at 1,000 x g 
for 10 min at 4°C. The supernatant fluid was removed with 
a pasteur pipette and stored. The remaining part (pellet) 
was rehomogenized, and the above process repeated until 
homogenation was complete. The supernatant fluids were 
pooled and diluted in 0.25 M sucrose to a volume of 1:16. 
This was centrifuged at 12,000 x g for 20 min at 4°C. The 
pellet was supended in homogenizing medium (0.25 M sucrose) 
and then washed twice in 0.25 M sucrose.
Purification of the tritosomes by sucrose gradient. The 
washed pellet was suspended in 45% sucrose to a volume of
2 ml/g of the initial fresh liver; 15 ml of this solution 
was placed on the bottom of Polyallomer centrifuge tube 
(Beckman Instruments, Inc., Palo Alto, CA.). Subsequently, 
15 ml of a 3 4.5% sucrose was carefully layered over this, 
and 8.5 ml of a 14.3% sucrose solution layered over the 
latter. The gradient was centrifuged at 32,000 x g for
3 hr in a Beckman ultracentrifuge and SW 27 type rotor.
The Triton-filled lysosomes (Tritosomes) were collected at
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the interface between the 8.5% and 14.3% sucrose layers.
The method of collection was by upward displacement using a 
6 0% sucrose solution, and collecting the drops in 2 ml 
volumes.
Determination of protein content of macrophage fractions and 
liver tritosomes.
The protein content of the different macrophage frac­
tions and liver tritosomes were determined by Folin assay.
The method used was that described by Lowry, et al. (52) with 
some modifications. A standard curve was determined using 
bovine serum albumin (BSA). The amount of protein in each 
sample fraction was determined by correlating it to the 
standard BSA curve. All assays were run in duplicates.
Proteinase-I (PrI) from cellular slime mold, Dictyostelium 
discoideum.
Proteinase I was supplied by Gustafson and diluted to 
appropriate concentration just before use.
Collection of sera for passive hemagglutination assays.
Whole blood was obtained from mice that had been anesthetized 
with ether (E.R. Squibb and sons. New York, NY.), and 
exsanguinated by an axillary incision. The blood was allowed 
to clot at room temperature (25®C) for about 1 hr, then 
"ringed" and left to incubate overnight at 4 °C. The serum 
was separated from the clot by centrifugation at 1,000 x g 
for approximately 10 min. The serum was dispensed into
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small vials, heated at 56°C for 30 min, and stored at -20°C.
Quantification of humoral (anti-LPS)antibodies. Antibodies 
specific for LPS from E. coli 0113 were determined by passive 
hemagglutination (PHA), (80). Sheep red blood cells (SRBC)
coated with LPS from E. coli 0113 were used as indicator 
cells (65). For sensitization, 1 mg of LPS from E. coli 
0113 was dissolved in 1 ml of 0.1 M phosphate buffer (pH 7.2) 
and then placed in a boiling water bath for 2h hr. Sensi­
tized sheep red blood cells were prepared by combining 2.5% 
(0.25 ml) of the washed SRBC originally collected in 
Alsever's solution and obtained from Colorado Serum Company, 
Denver, CO., 9 ml of phosphate buffered saline (PBS), pH 7.2; 
1 ml of the boiled stock LPS from E. coli 0113. The mixture 
was shaken and incubated at 3 7°C for 3 0 min. After 3 wash­
ings with cold PBS, the cells were resuspended in 10 ml of 
diluent (PBS containing 1% heat inactivated, SRBC-absorbed 
normal rabbit serum), to give a 2.5% sensitized sheep red 
blood cells (SSRBC). It was diluted to a concentration of 
0.5% immediately before use.
Normal sheep red blood cells were prepared by re- 
suspending the packed washed SRBC in microtiter diluent to 
a concentration of 0.5%. For the PHA test proper, 0.0 5 ml 
of diluent was added to each well of a microtiter plate 
(Titertek, Linbro Chemical Co., Inc., New Haven, C T .). Then 
0.05 ml of the test serum was added to the first well and 
serial two fold dilutions made with 0.05 ml dilutors (Cook
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Engineering Co., Alexandria, VA.). In all cases, duplicate 
tests were run. Next, 0.05 ml of the normal SRBC was added 
to the 12th well. The plate was agitated and then placed in 
a humidified chamber. Hemagglutination was recorded after 
2 hr incubation at 25°C and again after an overnight incuba­
tion at 4®C.
Titers were expressed as values of x, derived from the 
equation, x = log 2 (HD/2), where HD was the reciprocal of the 
highest dilution of sera which produced hemagglutination 
(51). (A positive hemagglutination is one that does not 
give the "button" control pattern). Thus the titer is the 
tube number of the endpoint when the first well contained a 
h dilution of the antiserum. Sera that gave no hemagglutin­
ation at the lowest dilution tested were arbitrarily assigned 
a titer of 0, i.e., a dilution of h. Titers were expressed 
as the geometric mean of the duplicate tests.
Measurement of the inhibition of LPS/anti-LPS reaction with 
macrophage, using ^^Cr labeled LPS. LPS was labeled with 
hexavalent ^^Cr by a modification of the method described 
by Braude, et a l . (13). A standard curve was first estab­
lished. The following were combined sequentially: 0.1 ml 
bovine serum (as a carrier), varying amounts of anti-LPS 
and enough PBS to bring the volume to 1 ml. The mixture was 
incubated for 30 min at room temperature (22-25°C). Then,
0.1 ml of ^^Cr labeled LPS was added to each tube. The 
mixture was incubated for 1 hr at room temperature and 0.5 ml
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of saturated (NH^>2 SO^ was added, the contents of the tubes 
were mixed and centrifuged at 1,000 x g for 30 min. The 
precipitate was washed once with 1 ml of 33% (NH^)2^0^ and 
then the precipitates were counted in a scintillation 
counter (Nuclear Chicago Corp., Des Plains, IL.).
The macrophage lysate was used to inhibit the LPS/anti- 
LPS reaction as follows : to a reaction tube were added 0.1 ml 
of cow serum, 0.1 ml of anti-LPS, varying concentrations of 
macrophage lysate, and PBS to bring the volume to 1.0 ml.
The mixture was incubated at room temperature for 3 0 min.
Then 0.1 ml of ^^Cr labeled LPS from E. coli 0113 was added 
to each tube. This was incubated for 1 hr at room tempera­
ture and 0.5 ml of saturated (NH^)2^0^ was added to each 
tube. The mixture was centrifuged and the precipitate 
washed once with 1 ml of 33% (NH^) 2 ^^^- The precipitate was 
counted and the percentage inhibition was correlated with an 
endotoxin equivalent as shown by the standard curve. The 
percentage inhibition was determined using the following
equation: % Inhibition = ^^^o ^^^x X 100
CPM^
where CPM^ was the count per min precipitated when no "cold" 
LPS was added, and CPM^ was the count per min when x yg/ml 
of "cold" LPS was added.
Cross-reactivity of lysosomal Pr I with anti-LPS. The cross­
reaction between lysosomal proteinase I (Pr I), and anti-LPS 
was determined by solid phase microtiter assay. Just before
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use, appropriate dilutions of the Pr I were made in a 1/10
dilution of 0.5 M bicarbonate buffer (pH 9.6). PBS-Tween
buffer (8 g NaCl, 0.2 g KCl, 0.008 M Na^HPO^, 0.2 g KH^PO^,
0.5 ml Tween-20, distilled H 2 O to make a volume of 1 £,
pH 7.2), was the working solution throughout the experiment.
Cooke microtiter plates (Dynatech Laboratories Inc., VA.),
were coated with Pr I (20 0 yl/well) by incubating over night
at 4®C. The wells were washed 6 times with PBS-Tween buffer,
and they were incubated in this buffer for 5 min prior to
décantation, to reduce non-specific binding. A serial
dilution of the anti-LPS serum was made (from 1/1 - 1/2 56),
and 200 yl of each dilution was added to each well. The last
well contained no anti-LPS serum. The plate was incubated
in a humified chamber at room temperature for 2 hr. The
plates were washed 6 times with PBS-Tween buffer, followed
by the addition of 200 yl (approximately 6.8 x 10^ cpm) of 
125 I staphylococcus protein A (New England Nuclear, North 
Billerica, MA.). The plate was incubated for 3 hr at room 
temperature. After washing 6 times with PBS-Tween, the 
wells were dried and cut from the plate with scissors. The 
radioactivity in each well was determined in a scintillation 
counter (Nuclear Chicago Corp., Des Plains, IL.). All tests 
were run in triplicate. A normal rabbit serum control was 
run side by side with the anti-LPS serum.
Inhibition of Pr I/anti-Pr I reaction by LPS from E. coli 
0113. The wells in the Cook microtiter plate were coated
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Cross-reactivity between macrophage lysate and lysosomal 
proteinate I . The Cooke microtiter plates were coated with 
Proteinase I (Pr I) (200 yl/well of 2 yg/ml) by incubating 
overnight at 4°C. Appropriate dilutions of the macrophage 
lysate (1/1 to 1/204 8) were made in test tubes and a constant 
amount (200 yl of 1/4000 dilution) of anti-Pr I added to each 
tube. These were incubated for 3 0 min and then 200 yl of 
each dilution mixture was added to the Pr I coated wells and 
incubated for 2 hr at room temperature. The last well con­
tained no macrophage lysate. After washing the wells,
200 yl (approximately 1.2 x 10^ cpm/200 yl) of staphylo­
coccus protein A was added to each well. This was incubated 
for 3 hr at room temperature at the end of which the wells 
were washed, dried and the radioactivity in each well was 
determined in a scintillation counter (Nuclear Chicago Corp.,
Des Plains, IL.). The amount of inhibition was measured by
X 100
P P M  —PPMthe equation: % Inhibition = o x
CPM_o
where CPM^ was the count per min in the well that had 0 
amount of macrophage lysate and CPM^ was the count per min 
in the well that had x amount of macrophage lysate.
Inhibition of LPS/anti-LPS binding by macrophage lysate.
The Cooke microtiter plates were coated with LPS from E. 
coli 0113 (200 yl/well of 25 yg/ml) by incubating overnight
at 4°C. Appropriate dilutions of the macrophage lysate were
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made (1/1 to 1/256) in test tubes and these were incubated 
with a constant volume (200 yl) of h dilution of anti-LPS 
for 30 min. After incubation, 200 yl of the dilution mix­
ture was added to each well and incubated for 2 hr at room 
temperature. The wells were washed 6 times with PBS-Tween
and then, 200 yl (approximately 1.2 x 10^ CPM/200 yl) of 
125 I Staphylococcus protein A was added to each well. After
a 3 hr incubation, the wells were washed, dried, and the
radioactivity in each well was measured by the equation:
% Inhibition = X 100
CPM^
where CPM^ was the count per min when no macrophage lysate 
was added, and CPM^ was the count per min when x dilution 
of lysate was added.
SDS-PAGE electrophoresis technique. The gel was prepared 
according to the method described by Studier (87), with some 
modifications. Stock solutions of the following were pre­
pared: 30 g acrylamide (Bio Rad, Laboratories, Richmond, 
CA.), and 0.8 g of N , N *-methylene bisacrylamide (Eastman 
Kodak Co., Rochester, NY.). This was made up to 100 ml 
with distilled water. A 15% separating gel was prepared by 
combining 15 ml of the acrylamide-bis stock solution; 3 ml 
of 1.5 M Trizma base (Sigma Chemical Co., St. Louis, MO.), 
pH 8.8; 0.3 ml of 10% Sodium dodecyl sulfate (SDS) (Matheson 
Colman and Bell, Norwood, CH.), in water ; 0.3 ml of 0.2 M 
EDTA (Fisher Scientific Co., Fair Lawn, NJ.); and 11.1 ml
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of distilled water. The mixture was degased for about 5 min 
and then 0.3 ml of freshly prepared 10% ammonium persulfate, 
and 0.015 ml of N,N,N',N'-tetramethylethylenediamine (TEMED) 
were added and the mixture was gently shaken. A spacer 
(blank) was inserted between the sandwiched plates and the 
mixture allowed to polymerize (about 20-30 min). After 
polymerization, the blank was removed and the top of the gel 
rinsed with distilled water. A blank was inserted, leaving 
a space of 1-2 mm above the polymerized (separating) gel.
A 4% stacking (spacer) gel was prepared by combining 4 ml of 
the stock acrilamide-bis solution; 1.88 ml of 0.5 M Trizma 
base, pH 6.8; 0.15 ml of 10% SDS; 0.15 ml of 0.2 M EDTA; and 
10.1 ml of distilled water. The mixture was degased and the 
0.15 ml of 10% ammonium persulfate and 0.007 ml of TEMED 
were added. The mixed solution was then applied to the 
polymerized separating gel. After the polymerization of the 
stacking gel, the blank was removed and the gel rinsed with 
the electrophoresis (Running) buffer [6 g Tris ; 28.8 g 
glycine (Sigma Chemical Co., St. Louis, MO.); 10 ml of 10% 
SDS; 10 ml of 0.2 M EDTA; with the volume adjusted to 1 Z 
with distilled water]. After the removal of the bottom 
spacer from the sandwich, the latter was clamped to the 
electrophoresis apparatus and then the bottom buffer chamber 
filled with the electrophoresis buffer. The top buffer 
chamber was filled after the junction between the sandwich 
and upper buffer chamber was sealed with 1.5% agar. Then
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the Pr I samples were applied to the gel. The Pr I samples 
applied to the gels were pre-treated with double strength 
sample buffer. The sample buffer contained 1 ml of 0.5 M 
Tris, pH 6.8; 1 ml of 10% SDA; 0.1 ml of 0.2 M EDTA; 0.02 g 
of di-thiothreitol (Sigma Chemical Co., St. Louis, MO);
1 ml of glycerol; and 1.9 ml H 2 O. The pre-treatment con­
sisted of mixing equal volumes of Pr I and sample buffer, 
and 10 yl of bromphenol blue dye (W. A. Taylor & Co., 
Baltimore, MD.), and incubating the mixture in boiling water 
for a standard 1 min. The gel was run at 100-150 V, 3-5 mA., 
for 3-4 hr at room temperature, til the tracking dye was 
about 1 cm from the bottom of the gel.
Preparation of the paper and the transfer of the proteins 
from the gel to the paper. The activated paper supplied by 
Gustafson was prepared by the method described by Alwin, 
et al. (39,42,58), with slight modification. The Whatman 
540 paper was cut into sheets (10 x 14 cm). The sheets were 
stacked on glass plate with a plastic screen in between 
each sheet. While stacking, 2.5 ml solution containing 2 g 
of m-nitrobenzyloxymethy1 pyridinum chloride (NBPC) (Sigma 
Chemical Co., St. Louis, MO.) and 1 g of sodium acetate 
per 2 5 ml were added to each paper. The papers now convert­
ed to nitrobenzyloxymethyl papers were washed twice in dis­
tilled water, and twice in acetone. After air drying, the 
NBPC treated papers were placed in large boiling bag contain­
ing 200 ml of 20% sodium dithionite (J. T. Baker Chemical Co.,
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Phillisburg, NJ.) (wt/vol). The sodium dithionite reduced 
the NBPC papers to amino benzyloxymethyl papers (ABM). The 
bag with the paper was heated in boiling water bath at 6 0°C 
for 3 0 min. The ABM papers were washed 3 times in the bag 
with distilled water, and then removed and placed in a 
plastic pan. They were washed once in the pan, with dis­
tilled water and then once with 3 0% acetic acid (approxi­
mately 500 m l ) . Finally, the papers were placed in large 
pyrex dish, washed 4 times with distilled water and then 
air dried on the screen. The ABM papers were stored in 
plastic bags at 4°C in a desicator. Just before use, the 
ABM papers were converted to the diazobenzyloxymethyl (DBM) 
form by incubating in a solution containing 64 mg NaNO^ 
(Mallinckrodt Chem. Works, St. Louis, MO.); 216 ml cold 
water and 24 ml of concentrated HCl for 30 min at 0°C (on 
ice bath). The papers were washed 5 times in cold distilled 
water.
The gel was laid on a scotch brite pad and the washed 
DBM paper laid over it. Another scotch brite pad was laid 
over the DBM paper. The setup was then put into the electo- 
blotting chamber (MRA Corp., Clearwater, FL-), with the paper 
facing the anode. The chamber was filled with approximately 
2500 ml of the electroblotting buffer (4 7 ml of 1.33 M
, and 2453 ml of cold distilled water, pH 6.5). The 
proteins were transfered by electroblotting for 3-4 hr at 
30-40 V and 3-5 A. After transfer, the paper was incubated
31
at room temperature in 1% ethanolamine, and 0.01 M Tris, 
pH 9.0, for 2 hr, to inactivate any remaining diazonium 
groups. The paper was washed 5 times with cold distilled 
water, dried on a screen and cut into small strips. The 
strips were stored in plastic bags (Oster Co-opt., Milwaukee, 
WI), at 4°C. Just before use, the strips were washed 5 
times in the "wash" buffer, containing 500 mM Tris; 150 mM 
NaCl; 1 mM EDTA; 0.05% Nonidet P-40 (NP-40) (Particle data 
Lab. Ltd., Elmhurst, IL.), pH 7.2, and 0.25% gelatin (J. T. 
Baker Chem. Co., Phillipsburg, NJ.) (as a carrier), then 
air dried.
Identification of specific proteins bound to DBM-paper 
(strips). The anti-Proteinase I (anti-PrI) stock solution 
supplied by Gustafson was diluted 1/4 0,000. Two strips of 
the DBM paper (Nos. 3 and 4) were treated with the 1/40,000 
dilution of anti-PrI, by incubating in a plastic boilable 
freezer bag for 3 0 min. After washing in the "wash" buffer 
5 times, the strips were incubated with 1 ml (approximately
o 12 55 X 10 cpm/10 yl) of I Staphylococcal protein A for 2 hr
in a double freezer bag sealed with a Touch-a-matic Seal
(Oster Corp., Milwaukee, WI). After incubation, the strips
were washed exhaustively, and air dried. The rest of the
strips (Nos. 1,2,5-10) were treated in separate bags for
3 0 min with a 3 0 min pre-incubated mixture of the following;
equal volumes of 1/40,000 dilution of anti-PrI and PrI 
(20 yg/0.5 ml) (Nos. 1 and 2); 1/40,000 anti-PrI and
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100 yg/0.5 ml of LPS from E. coli 0113 (Nos. 5 and 6) ; 
1/40,000 anti-PrI and 100 yg/0.5 ml of native protoplasmic 
polysaccaride (NPP), (Nos. 7 and 8); and 1/40,000 anti-PrI 
and 100 yl of macrophage lysate (Nos. 9 and 10). The strips 
were washed exhaustively with the "wash" buffer, to reduce
non-specific binding, then air dried, and incubated in 2 ml
3 125(approximately 5 x 1 0  cpm/10 yl) of I Staphylococcal
protein A for 2 hr. After incubation, the strips were wash­
ed 5 times in the wash buffer and air dried. An example of 
the scheme is shown below:
Treatments
Strip Nos. anti-Prl^^^ 
(dilutions)
Inhibited with
PrI LPS Npp m^
(c)
I protein A
3
4 
1 
2
5
6
7
8 
9
10
1/40,000
1/40,000
20 yg/.5ml — — —
20yg/-5ml - - -
— lOOyg/.5ml — —
— lOOyg/.5ml -
— - lOOyg/.5ml -
— — 100 yg/.5ml —
— — 100 yl
lOOyl
(a,b). The anti-PrI was pre-incubated with the different 
inhibitors for 3 0 minutes. Each mixture was then incubated 
with the corresponding strip for 30 min in a heavy duty
+
+
+
+
+
+
+
+
t
+
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boilable freezer bag (Oster Corp., Milwaukee, W I ) . The 
strips were washed thoroughly in the wash buffer.
(c) . (approximately 5 x 10 cpm/lOyl) of 2 ml of I 
staphylococcal protein A was added to the bag, then sealed 
with a Touch-a-matic seal (Oster Corp., Milwaukee, W I ) .
Autoradiography. The washed, air dried strips were auto­
radiographed with Kodak XAR 5, X-omat, AR film, in a Kodak X- 
omatic regular intensifying (KP 69065-A) screen. The film 
was incubated at -60°C for 24 hr. After incubation, the 
film was developed in X-ray developer solution (Kodak X-ray 
developer (Dektol,1:2), for 10 min, then transfered to the 
stop solution (Kodak short stop bath) for 3 0 sec, and finally 
it was fixed in Kodak rapid fixer (Kodak rapid fixer-X-ray) 
for at least 5 min. The film was washed exhaustively in 
"luke warm" water (20-30°C) and then blotted dry. The 
picture of the film was taken with a Polaroid MP-3 Industrial 
View Land Camera.
III. RESULTS
Generation of a pseudo-secondary antibody response with 
macrophage fractions. Previous studies (9,10,73), have 
shown that mice treated with toxins for macrophages, such 
as carrageenan and Min-U-Sil, elicited a pseudosecondary 
antibody response to LPS from E . coli 0113, when these 
mice were challenged with the LPS 21 days later. This 
observed phenomenon of pseudosecondary response was postu­
lated to be the consequence of damage to the macrophages 
with the subsequent release of products from the macrophages 
(or more specifically, the lysosomes). It was thought that 
these released products primed immunologically reactive 
lymphocytes so that the lymphocytes were able to recognize 
and to respond in a secondary fashion to immunodeterminants 
on the LPS molecule, when the latter was used as a challenge 
antigen. Based on the above view, experiments were designed 
wherein macrophages were harvested, fractionated and the 
different fractions used to prime mice for a pseudosecondary 
antibody response. Groups of 5 mice were injected intraperi* 
toneally on day 0 with either a macrophage fraction, a mouse 
liver tritosome fraction, or with PBS. Single doses of LPS 
from E. coli 0113 were given to each mouse on day 21, then 
the mice were bled on day 25, and the sera collected. Table
34
35
1, shows data from a preliminary experiment. The data show 
that mice treated with crude macrophage lysate (freeze- 
thawed 6 times) on day 0, and given a single dose of LPS 
from E. coli 0113 21 days later did generate a pseudosecond­
ary antibody response (group A ) . The magnitude of this 
response was comparable to the true secondary antibody response 
to LPS from E. coli 0113 (group C ) - The response of group A
was much higher than the pseudosecondary response of the
control group (group B) which received PBS on day 0 and a 
single dose of LPS from E. coli 0113 on day 21. Data pre­
sented in Table 2, show that mice treated with crude lyso­
somal fractions (12,000 x g pellet) and the crude 12,000 x g
supernatant fluid fractions of the cells, also gave a 
pseudosecondary antibody response (groups A and B ) . The 
12,000 X g supernatant fractions (group B), gave a higher 
response than the crude lysosomal fractions (12,000 x g 
pellet) (group A ) . This might be due to the fact that the 
soluble enzymes (hydrolases) were present in the supernatant 
fluid fraction as a result of lysosomal breakage during 
homogenization. The control groups (groups D and E) 
showed a very low response compared to group C, which is 
the true secondary antibody response.
Table 3, presents the data obtained with more purified 
lysosomal preparations from mouse cells. The protein content 
of each fraction was determined as described earlier, and 
the doses administered for priming contained equal amounts
Table 1
Generation of a pseudosecondary antibody response with crude macrophage lysate
Group Treatment^
Day 0 Day 21 Day 25
A m LPS 10
B PBS LPS 6
C LPS LPS 11
^*0.5 ml M0 lysate I.P.; 0.5 ml PBS I.P.; 1 ug LPS from E. coli 0113,I.P.
^'1 vig LPS from E. coli 0113 I.P.
^"Antibody titers were obtained by passive hemagglutination tests with LPS 
coated SRBC. Each value represents the antibody titer of sera pooled from 
5 mice. Titers are expressed as values of X, derived from the equation,
X= log^ (HD/2), where HD was the reciprocal of the highest dilution of 
sera that produced hemagglutination.
w
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Table 2
Generation of a pseudosecondary response with crude lysosomal macrophage
fractions and the supernatant fluid fractions.
Group Treatment^ b
Anti-LPS 
Antibody Titer
Day 0 Day 21 Day 25
A Lyso. LPS 8.2
B "SUP" LPS 10
C LPS LPS 16
D PBS LPS 6
E LPS PBS 4
^ ’0.3 ml lysosomal fraction i.p.; 0.3 ml supernatant fluid fraction 
i.p.; 1 yg LPS from E. coli 0113 i.p.; 0.5 ml PBS i.p.
^ ’1 yg LPS from E. coli 0113 i.p.
^'Antibody titers were obtained by passive hemagglutination tests with 
LPS coated SRBC. Each value represents the antibody titer of sera 
pooled from 5 mice. Titers are expressed as values of X, derived 
from the equation, X= log^ (HD/2), where HD was the reciprocal of 
the highest dilution of sera that produced hemagglutination.
(jj
Table 3
fractions and mouse liver ^  -  . #  - 1 >  — r' —tritosomes
Group Treatment^ b
Anti-LPS 
Antibody Titer
Day 0 Day 21 Day 25
A H0 lyso. LPS 7
B M0 sup. LPS 5
C LPS LPS 9
D PBS LPS 4
E Liver Trito. LPS 7
F Liver sup. LPS 7
^ ’5 pg M0 lysosome i.p.; 5 pg MJ& supernatant i.p.; 5 pg liver tritosomes 
i.p.; 5 pg liver supernatant i.p.; 1 pg LPS from E. coli 0113, i.p.
^*1 pg LPS from E. coli 0113, i.p.
^ 'Antibody titers were obtained by passive hemagglutination tests with 
LPS coated SRBC. Each value represents antibody titer of sera pooled 
from 5 mice. Titers are expressed as values of X, derived from the 
equation, X= log2 (HD/2), where HD was the reciprocal of the highest w
dilution of sera that produced hemagglutination. ^
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of protein. The purified liver tritosome fraction and the 
supernatant fluid portions of liver cells were used along 
with the macrophage fractions in the same experiment, so 
that quantitative comparisons could be made. The data 
obtained show that macrophage lysosomes (group A), liver 
tritosomes (group E), and the liver supernatant fluid 
fraction (group F), gave responses of similar magnitude.
The macrophage supernatant fluid fraction (group B ) , gave a 
somewhat lower response than the lysosomal fraction. This 
suggested that the lysosomal fraction had a higher concen­
tration of priming antigens (relative to the total protein) 
than the supernatant fluid fractions of the macrophage. The 
control group (group D) gave a response that was lower than 
the true secondary antibody response (group C ) .
Protein determination. The protein concentration of each 
macrophage fraction (total macrophage lysate, the crude 
lysosomes and the supernatant fluid fractions) and the mouse 
liver fractions (tritosome and the supernatant fluid frac­
tion) , were determined by using a modification of the Folin 
assay (52), as described earlier. Bovine serum albumin (BSA) 
was used as a standard. The total macrophage lysate contain­
ed the most protein, 1.5 pg/yl, while the supernatant fluid 
fraction from the macrophage preparation had the least amount, 
0.10 yg/yl.
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Generation of a pseudoseondary response with carrageenan in 
mice challenged with LPS from E . coli K23 5 , The data 
obtained when mice treated with carrageenan, were challenged 
with the E. coli K235 strain are presented in Table 4. On 
day 0, the mice in each group were either treated with 
carrageenan or PBS. A few hours later, groups C to F 
received a dose of LPS from E. coli K235, while groups A and 
B received nothing. On day 21, groups A, B, E, and F received 
a dose of LPS from E. coli K23 5, and groups C and D received 
no LPS. The group that was not treated with carrageenan on 
day 0 (group F) but had two doses of LPS K23 5 on day 0 and 
day 21 gave a true secondary antibody response. There was 
no pseudosecondary antibody response given in any of the 
groups. Groups E received two doses of LPS K23 5, but the 
mice in the group were treated with carrageenan on day 0.
The failure of group A to respond in a pseudosecondary 
fashion suggested that the immunological/immunochemical 
cross-reaction between products from the damaged macrophage 
and the challenge LPS was specific for LPS from E. coli 0113, 
since previous data (73) did suggest a pseudosecondary 
response when mice treated with carrageenan on day 0 were 
challenged with LPS 0113 21 days after toxin treatment.
Generation of pseudosecondary antibody response with 
Proteinase I . Data which will be presented later, indicated 
an immunochemical cross-reactivity between LPS from E. coli
Table 4
challenged with LPS from E. coli K 235
Group Treatment^ b c
Anti-LPS , 
Antibody Titer
Day 0 Day 0 Day 21 Day 25
A CAR none LPS 1
B PBS none LPS 1
C CAR LPS none 0
D PBS LPS none 0
E CAR LPS LPS 2
F PBS LPS LPS 7
5 mg CAR. i.p.
*̂ •1 yg LPS from E. coli K235, i.p.
^•1 vg LPS from E, coli K235, i.p.
d.Antibody titers were obtained by passive hemagglutination tests, with 
LPS coated SRBC. Each value represents the antibody titer of sera 
pooled from 5 mice. Titers are expressed as values of X, derived 
from the equation, X= log^ (HD/2), where HD was the reciprocal of the 
highest dilution of sera that produced hemagglutination.
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0113 and proteinase I (Pr I) (Cf. Figures 3 and 4). An 
attempt was made to prime for a pseudosecondary antibody 
response with proteinase I. The data generated from such a 
response are presented in Table 5. Three different concen­
trations of proteinase X, 1 ug/ml in group A, 10 ng/ml in
group B, and 100 pg/ml in group C, were used to prime the
mice at day 0 in each group. It required a high concentra­
tion of Pr I (100 yg/ml) to prime for a pseudosecondary 
response that was similar quantitatively to the true 
secondary response (group D ) . In all groups where Pr I was 
used for priming (even at 1 yg), the response was higher
than the control (group E), where the group received only
one dose of LPS from E . coli 0113.
The genetic requirement for the generation of a pseudo­
secondary antibody response. Previous data (73) showed 
that C3H/HeJ mice, which are non-responders to LPS, could not 
generate a pseudosecondary antibody response when these mice 
were treated with toxins for macrophage and then challenged 
with LPS from E. coli 0113 21 days later. This is as a 
result of a defective gene in this strain of mice, which 
causes a lack of ability of cells in these mice to recognize 
the signal from the lipid A portion of the LPS molecule. 
Various fractions of macrophage preparations were used in 
an attempt to generate a pseudosecondary response. Once 
again, as seen in Table 6 (in comparison to the RML swiss 
mice which are responders to LPS), C3H/HeJ mice could not
Table 5
Generation of a pseudosecondary antibody response with proteinase I
Group Treatment b
Anti-LPS 
Antibody Titer
Day 0 Day 21 Day 25
A 1 yg PrI LPS 7
B 10 yg PrI LPS 8
C 100 yg PrI LPS 10
D LPS LPS 15
E PBS LPS 5
^*PrI from slime mold, i.p.; 1 yg LPS from E. coli 0113; 0.5 ml PBS i.p.
^*1 yg LPS from E. coli 0113, i.p.
^ ’Antibody titers were obtained by passive hemagglutination tests with LPS 
coated SRBC. Each value represents the antibody titer of sera pooled from 
5 mice. Titers are expressed as values of X, derived from the equation 
X= log^ (HD/2), where HD was the reciprocal of the highest dilution of 
sera that produced hemagglutination.
w
Table 6
The genetic requirement for the generation of a pseudosecondary antibody response
Group Mouse Strain Treatment^ b
Anti-LPS 
Antibody Titer^
C3H/HeJ Day 0 Day 21 Day 25
A M0 1ysosome LPS 1
B M0 supernatant LPS 1
C LPS LPS 3
D
RML Swiss mice
PBS LPS 3
A M0 lysosome LPS 7
B M0 supernatant LPS 5
C LPS LPS 9
D PBS LPS 4
^'5 pg MIÛ lysosome, i.p.; 5 pg M0 supernatant. i.p.; 1 yg LPS from E. coli 0113 i
^•1 pg LPS from E. coli 0113, i.p.
c .Antibody titers were obtained by passive hemagglutination tests with LPS coated 
SRBC. Each value represents the antibody titer of sera pooled from 5 mice. 
Titers are expressed as values of X, derived from the equation, X= log- (HD/2), 
where HD was the reciprocal of the highest dilution of sera that produced 
Hemagglutination.
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generate a pseudosecondary response when primed with the 
various macrophage fractions. It was shown by Remington & 
Rudbach (73) that the induction of a pseudosecondary response 
occurred at the stage of B cell priming. Therefore, the 
various macrophage fractions probably primed the B lympho­
cytes, but since the mice lacked the genetic ability to 
react with the lipid A portion of LPS from E. coli 0113, 
there was no recognition of the second signal and therefore 
could not induce the pseudosecondary antibody response.
Immunochemical cross-reaction between LPS 0113 and macrophage 
products. An immunological inhibition assay was established 
to investigate cross-reactivity between LPS 0113 and macro­
phage products. Data presented in Fig. 1 show the results 
of such experiments. The inhibition of the homologous 
system (LPS reaction with anti-LPS), with various amounts of 
LPS, was compared to the inhibition of the LPS/anti-LPS 
reaction, by different dilutions of the macrophage lysate. 
Fig. 1, curve A, shows the expected increase in the amount 
of inhibition, as higher concentrations of LPS were added 
to the system. Also, Fig. 1, curve B shows the amount of 
inhibition when higher concentrations of the macrophage 
lysate were added to the system.
Although a radioimmunoassay had been established 
between macrophage products and LPS (Fig. 1), an attempt 
was made to quantify this inhibition by a different assay 
system. LPS from E. coli 0113 (25 yg/ml) was bound to a
46
Fig. 1 Comparison of the percentage inhibition of the
homologous system by LPS from E. coli 0113, and the
percentage inhibition by macrophage lysate, of the LPS
reacting with its antibody. The percentage inhibition
is calculated from the equation derived from,
CPM - CPM 1
% Inhibition = ---    ^ ^
CPMo
where CPM^ was the count per min when the amount of 
LPS from E. coli 0113 was 0 yg, and CPM^, was the 
count per min when the amount of LPS was x yg.
SYMBOLS :
Curve A: homologous (LPS/anti-LPS) system.
Curve B: inhibition by macrophage lysate.
M9 IP S
50 100
MÉ) dilutions.
"sj
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microtiter plate. Varying dilutions of the macrophage lysate 
containing an equivalent volume of 1/4 dilution of anti-LPS 
were added to the corresponding wells in the plate. Fig. 2 
shows that in this system, no inhibition of the reaction of 
LPS and anti-LPS by the macrophage extracts could be detected 
In fact, the amount of anti-LPS antibody binding to the 
plates increased as increasing concentrations of the macro­
phage lysate were added to the system.
Immunochemical cross-reaction between LPS and Proteinase I .
The immunochemical cross-reactivity between LPS from E. coli
0113 and Proteinase I (Pr I), was investigated by measuring
the binding of anti-LPS to Pr I . Microtiter plates were
coated with Pr I (2 yg/ml). After incubating overnight at
4®C, the plate was washed and varying dilutions of the anti-
LPS were added to corresponding wells on the plate. Varying
dilutions of normal rabbit serum were added to separate wells
125as a control. Radioactive I Staphylococcus protein A, 
was used as the indicator for antibody binding in the system. 
Data generated from such experiments are shown in Fig. 3. 
Curve A shows an increase in antibody binding to the solid 
phase, as the amount of anti-LPS added to the system was 
increased. At a dilution of 1/8, the curve starts to 
plateau, showing that the antigen was saturated. Compared 
to the control (curve B), there was little binding when 
normal rabbit serum was substituted for anti-LPS serum.
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Fig. 2. Immunochemical cross-reaction between LPS
from E. coli 0113 and macrophage lysate. LPS from
E. coli 0113 (25 yg/ml per well), was bound to the
microtiter plate. Varying dilutions of the M.0 lysate
were mixed with equal volume of a 1/4 dilution of anti-
LPS and the mixture added to the corresponding wells. 
125Radioactive I Staphylococcus protein A was the
indicator of binding. The percentage inhibition is
given by the equation, % Inhibition = ^^^o ^ ™ x  X 100
CPMo
where CPM^ was the count per min with no M0 lysate 
added to the anti-LPS, and CPM^ was the count per min 
when X dilution of the macrophage lysate was added to 
the antibody.
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Fig. 3. Immunochemical cross-reaction between LPS from
E. coli 0113 and Proteinase I (Pr I). Varying dilutions
of anti-LPS were added to wells coated with 2 yg/ml of
Pr I. The number of counts per min of the bound 
125radioactive I Staphylococcus protein A was used as 
the indicator system.
Symbols :
Curve A: Test experiment (Pr I coated plates reacted
with anti-LPS.
Curve B: Control test (Pr I coated plates reacted
with normal rabbit serum.
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The ability of LPS from E. coli 0113 to inhibit the 
reaction between proteinase I and anti-proteinase I, was 
tested by using a standard radioimmunoassay. Proteinase I 
was bound to the plate (2 yg/ml) and varying amounts of LPS 
from E. coli 0113 were added to a constant volume of 1/4,000 
dilution of anti-Pr I. As shown in Fig. 4 there was inhibi­
tion of the homologous system, by the added LPS. The 
specificity of the inhibition was checked by using LPS from 
the E. coli K235 strain. Fig. 5. The data show that LPS 
from E. coli K23 5 did not inhibit the binding of Pr I, to 
anti-Pr I; rather there was a decrease in inhibition (enhance­
ment in immune binding) of the homologous system, as increas­
ing amounts of the LPS were added.
Immunochemical cross-reactivity between lysosomal proteinase 
I (Pr I) and macrophage products.
An attempt was made to inhibit the reaction of protein­
ase I and anti-proteinase I, using macrophage lysate. Pr I 
(2 yg/ml), was bound to the plate and varying dilutions of 
macrophage lysate, mixed with an equal volume of 1/4,000
dilution of anti-Pr I, were added to the appropriate wells
125of the microtiter plate. Radioactive I Staphylococcus 
protein A was used to quantify binding of antibody to the 
plates. As shown in Fig. 6, the macrophage lysate inhibited 
the reaction of Pr I and anti-Pr 1 only slightly. At 
lower dilutions of the macrophage lysate, there was even an 
enhancement of binding of anti-Pr I to the proteinase I .
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Fig. 4. Immunochemical cross-reactivity between LPS
from E. coli 0113 and lysosomal Proteinase I (Pr I.
A constant amount (2 ijg/ml) of proteinase I was added
to the microtiter plate, and varying amounts of LPS
from E. coli 0113 added to a constant volume of a
1 2 R1/4,000 dilution of anti-Pr I. Radioactive I
Staphylococcus protein A was the indicator of binding.
The percentage inhibition is given by the equation,
% Inhibition = ~ x 100
CPM^
where CPM^ was the count per min at 0 ]ig of LPS and 
CPM was the count per min at x pg of LPS.
0/0 Inhibition.
w0"C(û N4Ui
P “ VI“Den W
O'
03 10k)m V»
n VI0 o
Q oQ
W
*
\
\
Ui
Ln
56
Fig. 5. Immunochemical cross-reactivity between
lysosomal Proteinase I (Pr I) and LPS from E. coli K23 5.
Pr I (2 yg/ml) was bound to the plate and varying amounts
of LPS K235 added to constant volume of 1/4,000 dilu-
125tion of anti-Pr I. Radioactive I Staphylococcus 
protein A was the indicator of binding. The percent­
age inhibition is given by the equation
% Inhibition = ~ x 100
CPM^
where CPM^ was the count per min at 0 yg LPS K23 5, 
and CPM^ was the count per min at x yg L P S .
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Fig. 6. Cross-reactivity between macrophage lysate 
and lysosomal Pr I. Pr I (2 yg/ml) was bound to the 
plate. Varying dilutions of the macrophage lysate 
were mixed with a constant amount of 1/4,000 dilu­
tion of anti-Pr I, and the mixture added to the
125corresponding wells. Radioactive I Staphylo­
coccus protein A was the indicator of binding. The 
percentage of inhibition was given by the equation,
% Inhibition = ~ X 100
CPM^
where CPM^ was the count per min with no macro­
phage lysate added to the anti-Pr I, and CPM^ was 
the count per min when x dilution of macrophage 
lysate was added to the antibody.
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An electrophoresis/electroblotting technique (39,58) 
was used to analize further the immunochemical relation­
ship between LPS, lysosomal Pr I, and macrophage products.
Pr I (6 yg/600 yl) was applied to an SDS-PAGE gel, and 
subjected to electrophoresis. Following electrophoresis, 
the proteins were electroblotted (transferred) to diazobenzyl- 
oxymethyle paper (DBM-paper). The DBM-paper was cut into 
1 cm strips. The ability of Pr I, LPS from E. coli 0113,
NPP, and macrophage lysate to inhibit the binding of anti- 
Pf I to the Pr I on the DBM strip was investigated. If anti-
Pr I binds to the Pr I on the strip, there will be an
125antigen-antibody complex formed. When I protein A which
binds to the Fc portion of IgG molecules is added, it will
bind to the antibody complex. Therefore, a reduction in 
125the I protein A binding indicates an inhibition of reac­
tion between Pr I and anti-Pr I . Such reactions could be 
visualized by autoradiography. The data from such an 
experiment are shown in Fig. 7. The degree of inhibition 
of the homologous system by Pr I, LPS 0113, NPP, and macro­
phage lysate was compared to the homologous system (lanes 
3 and 4), which is the reaction of anti-Pr I and Pr I.
Pr I (lanes 1 and 2) showed a reduction in the binding of
protein A to the Pr I/anti-Pr I complex. There was a
125partial reduction (inhibition) in the binding of I 
protein A to the Pr 1/Anti-Pr I complex (lanes 5 and 6).
The inhibition of the homologous system by macrophage lysate
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Fig. 7. Immunochemical cross-reaction between macro­
phage products, LPS from E. coli 0113, and lysosomal 
proteinase I. Electrophoresed proteinase I was co­
valently conjugated to a DBM-paper. The strips of
the paper were stained with different reagents.
12 5Radioactive I Staphylococcus protein A was the 
indicator system. The papers were autoradiographed.
Symbols :
Lanes 3 and 4: Stained with 20 yg/0.5 ml Pr I;
1/40,000 dilution of anti-Pr 1.
Lanes 1 and 2: Stained with 1/40,000 dilution
of anti-proteinase I.
Lanes 5 and 6: Stained with 1/40,000 dilution of anti-
Pr I; and 100 yg/0.5 ml LPS from E. coli 
0113.
Lanes 7 and 8: Stained with 1/40,000 dilution of anti-
Pr 1 and 100 yg/0.5 ml NPP.
Lanes 9 and 10: Stained with 1/40,000 dilution of
anti-Pr I and 100 yg lysate.
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(lanes 9 and 10) was inconclusive, since the control experi­
ment with NPP (lanes 7 and 8) showed the same degree of
1 2 Sreduction (inhibition) in I protein A binding.
Isolation of Gram negative (lactose +) organisms.̂
Escherichia coli is a gram negative lactose positive bacteria, 
which is a normal flora in the intestinal tract of many 
organisms. Since the presence of LPS from indigenous micro­
flora of E. coli could affect the response of the admin­
istered exogenous LPS, it was necessary to investigate 
whether there was any E. coli 0113 strain present in the gut 
of the strain of mice used in the study. The intestinal 
contents (large and small intestines), fecal droppings from 
Swiss-Webster mice derived from RML were cultured in an 
attempt to isolate gram negative lactose positive organisms. 
The intestinal contents, and fecal droppings were homogenized 
in PBS and the homogenate diluted serially (1/10 - 1/100,000) 
in PBS- The various dilutions were plated on McConkey agar, 
which is a selective medium for gram negative, lactose 
positive organisms; also, nutrient agar plates were streaked 
with the various dilutions of the homogenate. After a 24 hr 
incubation, plates with between 50 to 300 colonies were 
counted. The plate that contained a 1/1,000 dilution had 
a total colony count of 110, of which 8 distinct (different) 
colonies were detected. This represented a 7.2% lactose 
positive bacteria on the plate. Each of the colonies was 
restreaked for isolation and incubated for 12 hr. After
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incubation^ each colony was suspended in a drop of E. coli 
0113 antiserum on a slide and examined for agglutination. 
Also the colonies were tested with fluorescien labelled anti 
0113 antibody. There was neither an agglutination nor 
fluorescence in either of the tests. Other biochemical 
tests with triple sugar iron agar (TSI), Sulfur Indole 
Motility agar (SIM) were negative for Escherichia coli.
The only gram negative enteric bacteria found in all the 
isolates were the genera Klebsiella (lactose positive) and 
Proteous (lactose negative). The above data therefore 
suggested that E. coli 0113 strain was not present in the 
intestinal or fecal contents of the mice used for the study.
^ "This work was done by Ms. Sheri Henry and Ms. Vicky 
G. as a summer project in Stella Duncan Memorial 
Research Institute Laboratory, Missoula, Montana.
IV. DISCUSSION
The results of this study established an immunological/ 
immunochemical relationship between LPS from E. coli 0113 
and macrophage (or lysosomal) products. The data presented 
indicate that products released from the macrophage were 
responsible for priming the mice, and the consequent genera­
tion of a pseudosecondary antibody response when the mice 
were challenged with a single dose of LPS 21 days later. In 
addition, the results indicated an immunochemical cross­
reaction between LPS from E. coli 0113, and proteinase I 
from the cellular slime mold, Dictyostelium discoideum.
Previous studies (9,10,73), showed that mice treated 
with toxins for macrophages, such as carrageenan and silica, 
could generate a pseudosecondary antibody response, when 
these mice were challenged with a single dose of LPS from 
E . coli 0113, 21 days after toxin treatment. The magnitude 
and kinetics of this pseudosecondary antibody response were 
similar to the true secondary antibody response to two doses 
of LPS from E. coli 0113. It was hypothesized that materials 
released from lysosomes of toxin-disrupted macrophages 
might be responsible for priming mice to give the enhanced 
response to LPS.
The materials in the macrophage (or lysosome) respon­
sible for this immunological priming should share structural
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similarities to some part(s) of the LPS 0113 molecule. A 
number of considerations led to the view that the cross­
reactive determinants in LPS from E. coli 0113 and macro­
phage lysosomes might be structurally related to N-acetyl- 
glucosamine-l-phosphate. These included the following 
points: 1) Lipid A of LPS contains acylated analogs of this 
sugar-phosphate; 2) Precursor forms of some lysosomal enzymes 
in animal cells contain this sugar-phosphate, and 3) Studies 
by Pazur (40) and by Gustafson et al. (34) have shown that 
this sugar-phosphate is an immunodominant determinant both 
in bacterial polysaccharides (40) and in a lysosomal enzyme 
(i.e. Proteinase I) from the cellular slime mold (34).
In attempting to evaluate this hypothesis, studies 
were conducted to assess the immunological relationships 
outlined below.
MACROPHAGE
111
Proteinase I LPS 0113
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Relationships between LPS 0113 and Macrophage Products; 
Generation of a pseudosecondary antibody response with 
macrophage fractions. Using various macrophage fractions, 
it was possible to obtain a pseudosecondary antibody response 
to LPS 0113. The data suggested that the macrophage products 
primed the mice for the observed pseudosecondary antibody 
response, when these mice were challenged 21 days later with 
LPS from E . coli 0113. One group of materials in the macro­
phage (or lysosome) which might be responsible for this 
immunological priming are glycoproteins. Other possibilities, 
however, do exist. For example, it was possible that the 
macrophage might have been contaminated by endogenous LPS 
from the mice, also it was possible that the medium used 
might contain some LPS from E. coli 0113 as contaminants.
The first possibility (endogenous LPS contamination), would 
be considered unlikely for the generation of the pseudo­
secondary antibody response, since attempts to isolate 
E. coli 0113 serotype from the strain of mice used for the 
study were negative. Antibody response to LPS is specific 
and a secondary antibody response could be elicited in mice 
only if LPS from the same serotype of E. coli was given in 
both primary and secondary doses. The absence of E. coli 
0113 in the isolates suggests then that something other than 
endogenous LPS was responsible for the priming. Probably 
more compelling evidence against the endogenous LPS contami­
nation is as follows: If there was significant amount of
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endogenous LPS present in mice before the macrophage lysate 
was injected into the mice, the magnitude of the pseudo­
secondary response would be comparable to the response when 
only a singie dose of LPS from E. coli 0113 was given on day
0 or on day 21, since in both cases the LPS already present
in the system could have been recognized by the challenge 
dose of LPS from E. coli 0113. Also LPS contamination from 
the medium could not have been responsible for the immunolog­
ical priming because the same medium was used for all the 
groups of mice. The same magnitude of pseudosecondary 
response could have been observed in all the test groups 
if the medium was contaminated with LPS. In order to sub­
stantiate the theory that products from macrophages (or more 
specifically lysosomes) cross-reacted with specific determi­
nants on the LPS from E. coli 0113, LPS of a different sero­
type from E . coli was used in an attempt to generate a pseudo­
secondary response. Previous work had shown (73), that the 
basis for the generation of the pseudosecondary response 
occurred on the priming stage. The challenge dose with LPS 
0113 on day 21 was a second signal which was recognized by 
the already sensitized memory B lymphocytes. This recogni­
tion was specific, because LPS from E . coli K 23 5 could not 
be recognized by the cells already primed by the products 
released as a result of the treatment with carrageenan or 
Min-U-Sil; therefore, a pseudosecondary antibody response 
was not generated.
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Immunological cross-reactions between LPS 0113 and macrophage 
products. Since the macrophage lysate was shown to prime mice 
for a pseudosecondary antibody response on challenge with 
LPS from E. coli 0113, immunodeterminants of materials in 
the macrophage lysate responsible for this priming should 
cross-react immunologically with the LPS. Evidence support­
ing this view was obtained using standard radioimmunoassay 
techniques. Determinants in the macrophage lysate competed 
with LPS molecule for the binding sites on antibodies to 
LPS from E. coli 0113. A different assay system (solid phase) 
wherein LPS 0113 was coated on the plates, and the reaction 
of the LPS with anti-LPS inhibited with macrophage lysate, 
showed no inhibition. It is most likely that the difference 
in results here was because of the sensitivity of the two 
assay systems. The solid phase radioactive binding assay 
was limited by the number of proteins bound on the plate, 
and therefore less sensitive to detect the small amount of 
cross-reactive antigen.
The genetic requirement for the generation of pseudo­
secondary response. The C3H/HeJ mice are non-responders to 
LPS, because of a defective autosomal dominant gene (82) .
As a result of this defect, the receptor cells lack the 
ability to react with the lipid A portion of the LPS molecule 
(82,91). It was shown that if C3H/HeJ mice, treated with 
carrageenan or Min-U-Sil were challenged with LPS 21 days
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later, the mice did not generate a pseudosecondary antibody 
response (73) . These mice could not respond to the second 
signal of LPS because of the genetic defect, and therefore 
could not mount a secondary antibody response to LPS. The 
various fractions of the macrophage lysate were used in an 
attempt to generate a pseudosecondary antibody response in 
the C3H/HeJ mice; once again, these mice could not be induced 
to respond secondarily to LPS from E. coli 0113. These data 
support the hypothesis that products, released from the 
macrophage (lysosome) that were priming the mice, were doing 
so in a manner similar to the induction of a true secondary 
response to two doses of LPS. Thus, the generation of a 
pseudosecondary antibody response required the priming of 
the B lymphocytes with the macrophage products on day 0. 
However, the mounting of an anti-LPS secondary response 
depended on the recognition of LPS immunodeterminants by the 
previously sensitized B lymphocytes.
Relationships between LPS 0113 and Proteinase I: Attempts
to generate a pseudosecondary response with Proteinase I .
The macrophage lysate (lysosomal contents) contained factors 
that could prime mice for a pseudosecondary response to LPS 
0113, when challenged with the latter; and proteinase I is 
a lysosomal product which contains carbohydrates with struc­
tural similarities to those in LPS. The question was, could 
proteinase I prime mice for a secondary response that could
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be elicited by LPS from E. coli 0113? Attempts were made to 
generate a pseudosecondary antibody response with proteinase
I. The results of such investigations indicated some 
response, that was heightened over the primary level, 
especially at higher doses of the proteinase I. The fact 
that a comparable result (same magnitude of response) to the 
true secondary response was not obtained, could be explained 
by the fact that only a small fraction of the LPS molecule 
might share the structural similarities. The heightened 
response of the mice over the primary level, at higher dose 
of the proteinase I indicate an immunological cross-reaction 
because of structural similarities. It was possible that 
the proteinase I could have been contaminated by LPS since 
Dictyostelium discoideum used for the isolation of proteinase 
I was cultured on E. coli. This possibility would be un­
likely because the magnitude of the pseudosecondary response 
was dependent on the amount of proteinase I used for priming. 
The highest dose (100 yg) gave the most response, while a 
1 yg dose gave the least response. If there was enough 
endogenous LPS present in the purified proteinase I as to 
cause such priming, then the magnitude of the pseudosecondary 
response could have been similar irrespective of the amount 
of proteinase I used for priming. Besides, the control 
experiment where only one dose of LPS was given as a 
challenge dose gave very low response, compared to the true 
secondary response or the pseudosecondary response with
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proteinase I. Therefore, the data suggest that the lyso­
somal products in the slime mold which contain carbohydrates 
with structural similarities to those in LPS from E. coli 
0113 might be responsible for the immunological priming.
Immunochemical cross-reaction between LPS and proteinase I .
Because of the structural similarities between the carbohy­
drate portions of proteinase I and LPS, it was proposed that 
the determinants on proteinase I should cross-react, 
immunologically, with related structures on the LPS molecule. 
It was hoped that by establishing a cross-reacting system 
between the proteinase I and LPS, the same system could be 
used to confirm the cross-reactivity between LPS and the 
macrophage products. The rationale was that if an immuno­
chemical cross-reactivity was established between the LPS
and proteinase I, then it was likely that the macrophage
lysosomes which contain a number of glycoprotein hydrolases 
might have similar cross-reactivity with the proteinase I 
and L P S .
A solid phase assay was established to measure this 
cross-reactivity. There was a definite increase in the amount 
of anti-LPS binding to microtiter wells coated with proteinase 
I as increasing amounts of anti-LPS were added. This reac­
tion was specific for the anti-LPS because the control exper­
iment with normal rabbit serum showed no binding of IgG from 
the normal sera to proteinase I.
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When two molecules that share structural similarity 
are presented to the combining sites of an antibody specific 
to one of the molecules, there would be competition for 
binding on the antibody molecule. Consequently, the binding 
of the homologous molecule to the antibody specific to it 
will be inhibited by the heterologous molecule.
Since other data (34,40) indicated that LPS shared 
some structural similarity with the proteinase I, there 
should be competition between the LPS molecule and the 
proteinase I molecules for binding to antibodies specific 
for the proteinase 1 molecule. This was shown to be the case 
since LPS from E. coli 0113 could inhibit the reaction 
between proteinase I and anti-proteinase I. The specificity 
of this inhibition was checked by using LPS from a different 
strain of E. coli (E. coli K23 5). It was shown that LPS 
from E. coli K23 5 did not inhibit the binding of proteinase 
I to anti-proteinase I; in fact, there was a slight enhance­
ment of the homologous reaction.
SDS - Polyacrylamide gel electrophoresis is a powerful 
technique for analyzing protein components. The various 
protein components of the proteinase I were electrophoreti- 
cally separated and exposed on the gel. The results from 
the autoradiography indicated some inhibition by LPS of 
proteinase I and anti-proteinase I binding. The degree of 
inhibition here was not as pronounced as in the other assays 
such as the radioactive binding assay reported earlier.
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This might be due to the nature of the system used. The 
proteinase I did undergo treatment in SDS. There might 
have been some dénaturation of the protein. Besides, the 
success of the assay depended on the ability of the proteins 
to be covalently linked to the DBM-paper. The degree of 
inhibition would therefore depend on the ability of the LPS 
to stain the protein on the paper. An attempt was made to 
subject the macrophage (lysosomes) to electrophoresis and 
stain with anti-proteinase I and/or anti-LPS, but it was 
unsuccessful- Either that the macrophage (lysosomal) contents 
could not be separated into different bands on the gel, or 
they could not be covalently linked to the paper.
Relationship between Proteinase I and macrophage products: 
Immunochemical cross-reactivity between macrophage products 
and Proteinase I . If macrophage (lysosomal) products were 
shown to cross-react immunologically with proteinase I, then 
the macrophage (lysosomal) products should inhibit the 
binding of proteinase I to anti-proteinase I. However, 
there was no inhibition of the proteinase I and anti-protein­
ase I reactions by macrophage lysate. At lower dilutions of 
the macrophage lysate, there was even an enhancement instead 
of inhibition. The absence of inhibition, could be the 
result of the very small amount of cross-reactive antigen 
material contained in the lysate, relative to the sensitivity 
of the assay system. It should be noted that there is an 
extreme sensitivity of antigenic priming for a secondary
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response, hence the pronounced responses observed. The 
very small cross-reactive antigen was enough to cause the 
priming, but in the solid phase radioactive binding assay, 
different molecules bind to the plate; not all these mole­
cules could cross-react with the small amount of cross- 
reactive antigen material in the macrophage. Therefore, 
this particular assay system could not pick up the cross­
reactive antigen.
Proposed and proved relationships between LPS, macrophage 
and proteinase I .
Macropha<
The rationale for using proteinase I system in estab­
lishing the immunological/immunochemical cross-reactivity 
between LPS from E. coli 0113 and materials from macrophage 
(lysosome), was that macrophages contained lysosomal pro­
ducts which shared structural similarities with LPS from 
E. coli 0113 . Also, Pr I is a lysosomal product which con­
tains carbohydrates with structural similarities to those
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in LPS. Since Pr I was readily available, a system that 
determined an immunochemical cross-reactivity between Pr I 
and LPS from E. coli 0113 was established. Using the same 
system, an immunochemical cross-reactivity was established 
between Pr I and macrophage products.
The products (materials) in the macrophage (or more 
specifically lysosomes) contained determinant(s) similar 
to the structures in the LPS from E . coli 0113. This anti­
genic similarity was responsible for the pseudosecondary 
antibody response when the mice that were primed with 
materials from the macrophage (lysosome) at day 0 were 
challenged with LPS from E, coli 0113 21 days later. In 
addition to the immunological priming with materials from the 
macrophage and the subsequent ellicitation of a pseudo­
secondary antibody response on challenge with LPS from E. 
coli 0113, the materials from the macrophage inhibited the 
reaction of LPS and anti-LPS from E_̂  coli 0113. It is 
obvious then that the cross-reactive material is common to, 
or closely related in the two systems. It is believed that 
this cross-reactive material might be a glycoprotein.
If the cross-reactive material in the LPS is a glyco­
protein, it is likely that lysosomal proteinase I which 
is a glycoprotein should react immunochemically with the LPS 
molecule. By establishing a radioactive binding assay, it 
was possible to show that Pr I cross-reacted with anti-LPS 
molecule from E. coli 0113. Besides, LPS from E. coli 0113,
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inhibited the binding of Pr I to anti-Pr I.
The macrophage lysosomes contain a number of glyco­
protein hydrolases^ and therefore the cross-reactive anti­
gens which are believed to be glycoproteins should be 
recognized by lysosomal Pr I which is a glycoprotein. The 
data obtained was insufficient to establish a conclusive 
relationship between macrophage products and Pr I. Mice 
treated with Pr I ellicited a pseudosecondary antibody 
response to LPS when challenged with LPS 21 days later. 
Because the cross-reactive material might be small, an 
immunological response (generation of a pseudosecondary 
response) was generated only at higher concentration of 
Pr I (Table 5). Indirectly by using lysosomes from the liver 
of mouse, a precipitation reaction was established between 
anti-Pr I and the lysosomes.
This common cross-reactive material seems to have 
been selected, and preserved throughout evolution. Bacteria 
is one of the most primitive organisms, and higher up in 
the scale are the cellular slime mold, which possess this 
cross-reactive material, and then the higher organisms 
(animals), do possess this cross-reactive material also.
It is therefore possible that the immunological/immuno­
chemical cross-reactivity between the LPS molecule, materials 
from the macrophage (or lysosomes) and the lysosomal Pr I, 
is due to a cross-reactive antigen that has been selected 
for and preserved throughout evolution. This antigenic
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mimicry between different organisms might be important in 
the compatibility of animal hosts and parasites and perhaps 
in plant-parasite interactions.
The data presented in this study do confirm previous 
work from this laboratory (10,73). Becker and Rudbach 
observed the phenomenon of pseudosecondary antibody response 
when mice treated with toxins for macrophages were challenged 
with LPS from E. coli (0113, 21 days later. Remington's data 
showed that the generation of this pseudosecondary response 
was a phenomenon that occurred at the level of priming the 
B lymphocytes for a secondary anti-LPS response, and that 
the kinetics and the genetic requirements for this response 
were identical to the true secondary antibody response.
The macrophage (lysosomal) products primed mice for a 
pseudosecondary antibody response on challenge with LPS 0113 
21 days later. In addition to the fact that this phenomenon 
occurred at the level of priming B lymphocytes for anti-LPS 
response, the antigen used for challenge at the secondary 
level was critical. Only a molecule (antigen) that was 
recognized by the sensitized B lymphocytes could respond 
to the generation of anti-LPS secondary response.
Over the past years, there has been an increased 
interest in the chemistry and the structure of cell surfaces. 
This is as a result of the demonstrated roles of glyco- 
macromolecules in self-recognition, as virus receptors, in 
membrane transport, in host-parasite compatibility, and in
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other specific cell-cell interactions (22,64,66,68). One 
of the areas the glycomacromolecules have played an impor­
tant role is the antigenic mimicry between certain organisms 
and body tissues (25,84). Antigen sharing might be of 
medical importance both as a limiting factor in the develop­
ment of diseases and also might have a significant role in 
the pathogenesis of autoimmune-like diseases. The present 
study showed such antigen sharing. The macrophage (lyso­
somal) products might be involved in such reactions with 
E. coli, when there is an infection, and a subsequent 
autolysis of the former in the system. Future aspects of 
this study might involve the characterization of the mole­
cules involved in this immunological/immunochemical cross­
reactivity between LPS, macrophage (lysosome) products and 
lysosomal proteinase I. Such characterization would make 
it possible to understand the common origin of the antigens 
found in such diverse organisms as man, bacteria and the 
cellular slime mold.
Conclusion. Products released from the macrophage (or 
lysosome) were responsible for priming mice for a pseudo­
secondary antibody response to LPS from E. coli 0113, when 
these mice were challenged with LPS 21 days later. This 
response was specific because LPS from a different strain 
of E. coli (E. coli K235), could not be used to trigger a 
pseudosecondary antibody response. At higher proteinase I 
concentrations, there was substantial generation of pseudo­
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secondary antibody response. Thus, an immunological cross­
reactivity does exist between the LPS molecule and the 
lysosomal proteinase I. As shown in Figures 3 and 4, an 
immunochemical cross-reactivity exists between the LPS 
and the lysosomal glycoproteins of proteinase I. More data 
are needed to confirm the cross-reactivity between macro­
phage and Pr I. On the basis of the data obtained so far, 
a "triangular" relationship may exist between the macrophage 
(or more specifically lysosomal) products, the LPS, and 
lysosomal proteinase I. Therefore, there is an immunodomi­
nant molecule(s) common to the three systems. This immuno­
dominant determinant is responsible for the antigenic mimi­
cry between the LPS and macrophage products.
V . SUMMARY
Previous studies (73) have indicated the kinetic and 
genetic similarities in the generation of a true secondary 
antibody response to LPS and pseudosecondary antibody 
response. Macrophage toxins (carrageenan and Min-U-Sil), 
caused the destabilization of the macrophage which conse­
quently led to the autolysis of the lysosomes. Previous data 
(73) indicated that if mice treated with such toxins were 
challenged with LPS from E. coli 0113, 21 days later, there 
was a generation of a pseudosecondary antibody response.
The effect of this response was shown to be exerted at the 
priming stage (73). In order to find out whether the 
molecules released from the damaged macrophage were respon­
sible for priming the B lymphocytes, various immunological/ 
immunochemical reactions between the products released from 
the damaged macrophage, LPS, and proteinase I, a system that 
has some structural homologies to the macrophage lysosomes 
and LPS molecule, were investigated.
The macrophage (lysosomal) products primed mice for 
a pseudosecondary antibody response comparable in magnitude 
to the true secondary antibody response to LPS from E. coli 
0113. Higher doses of proteinase I primed mice for a 
pseudosecondary antibody response to LPS as well. Since one
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of the requirements for the generation of the pseudosecondary 
response is that the sensitized B lymphocytes recognize the 
receptors on the LPS molecule, therefore as expected C3H/
HeJ mice, which are genetic non-responders to LPS, did not 
generate the pseudosecondary antibody response in any of 
the systems studied. Also, LPS from E. coli (E. coli K 235), 
a strain of E. coli other than 0113, failed to generate a 
pseudosecondary antibody response.
Various radio-immunoassays were employed to determine 
quantitatively the relationship between LPS from E. coli 
0113 and macrophage extracts. Furthermore, the immunochemi­
cal relationships between proteinase I and the LPS molecule 
was studied. The lysosomal proteinase I contains glyco­
proteins, some of which are structurally similar to the 
oligosaccharide portions of the LPS molecule; an immuno­
chemical cross-reactivity was established between the two 
systems.
Autoradiographic experiments showed an immunochemical 
cross-reaction between proteinase I and LPS 0113. The 
immunochemical cross-reaction between proteinase I and pro­
ducts from the macrophage (lysosome) was inconclusive.
A relationship was proposed which linked LPS and 
macrophage (lysosomal) products, LPS and proteinase I, and 
maybe Pr I and macrophages. The immunodominant determi­
nant (s) in the three systems, might be structurally common. 
The products released from the damaged macrophage have this
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immunodeterminant group(s), and were responsible for priming 
the mice for a pseudosecondary antibody response on 
challenge with LPS 0113. Therefore, the phenomenon of 
pseudosecondary antibody response was due to the antigenic 
mimicry between determinant(s) on LPS from E. coli 0113 
and the same or closely related determinants in the macro­
phage (lysosome).
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